Financials of Aurobindo Pharma Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Aurobindo Pharma Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6,4736,8517,2197,3527,5807,5677,7967,9798,3827,8688,2868,6468,853
Expenses +5,4775,7025,8465,7535,9205,9496,2306,4016,6226,2656,6086,8737,103
Operating Profit9961,1491,3731,5991,6601,6181,5661,5781,7601,6031,6781,7731,750
OPM %15%17%19%22%22%21%20%20%21%20%20%21%20%
Other Income +1354718816314221136159135107122123117
Interest565768768911111311811598959398
Depreciation346327418423354404382419444406429465479
Profit before tax7308121,0761,2621,2301,3241,2071,2001,3351,2071,2761,3391,291
Tax %31%30%30%26%26%31%32%30%32%32%34%32%29%
Net Profit +506570752940907918817846903824848910921
EPS in Rs8.649.7412.9215.9815.5115.6914.0714.5615.5614.2014.6115.6715.86

Financials of Aurobindo Pharma Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +12,10313,77214,91016,46319,56423,09924,77523,45524,85529,00231,72433,653
Expenses +9,52410,57911,46912,69115,61218,24919,49719,06021,14823,17625,17326,807
Operating Profit2,5793,1933,4413,7723,9524,8495,2784,3963,7075,8266,5516,846
OPM %21%23%23%23%20%21%21%19%15%20%21%20%
Other Income +81200115105701663,195152291366622428
Interest16025767782633057449140290457384
Depreciation3333924285586689671,0551,1271,2451,5221,6491,778
Profit before tax2,1682,7443,0613,2413,0913,7437,3443,3732,6124,3805,0665,112
Tax %28%26%25%25%24%24%27%22%26%28%31%31%
Net Profit +1,5712,0242,3012,4232,3642,8445,3342,6471,9283,1693,4843,503
EPS in Rs26.9834.6139.2941.3640.3648.5691.0545.2032.9054.1560.0260.34
Dividend Payout %8%7%6%6%6%6%4%20%23%8%0%0%

Financials of Aurobindo Pharma Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital295959595959595959595858
Reserves5,1277,2299,31311,62213,83216,76621,87124,51726,78129,78432,59537,833
Borrowings +4,4515,0413,3644,7706,9675,8265,3392,8515,2866,6488,2638,073
Other Liabilities +3,3033,5683,4644,4925,4146,1136,1476,2117,3798,2278,56612,538
Total Liabilities12,91015,89616,20020,94226,27128,76533,41633,63839,50544,71749,48258,502
Fixed Assets +3,7064,1804,8346,5218,4759,3969,37410,53211,02414,49314,79419,611
CWIP4208481,4581,5831,6681,9863,0623,7475,3903,8694,9003,009
Investments201232463123605555919975433722521,051
Other Assets +8,76510,7459,66212,52715,76816,82720,39018,36222,54925,98329,53634,831
Total Assets12,91015,89616,20020,94226,27128,76533,41633,63839,50544,71749,48258,502

Financials of Aurobindo Pharma Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +1,2371,4203,2791,9551,6514,3813,3295,0162,3872,4353,9255,526
Cash from Investing Activity +-1,017-1,446-1,787-1,927-2,904-1,563597-3,211-3,971-4,242-1,866-3,459
Cash from Financing Activity +93365-1,9158641,919-1,947-1,365-2,9691,814800120-1,269
Net Cash Flow313340-4248926668712,561-1,164230-1,0072,178799
Free Cash Flow491-1461,5947141142,9691,5032,693-323-1,0671,4082,468
CFO/OP67%67%118%70%61%106%87%143%84%72%86%107%

Financials of Aurobindo Pharma Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days10712268686468526266616677
Inventory Days239240246317304289333272275284295326
Days Payable1361461221281079710397125129117151
Cash Conversion Cycle210217191257260260282237216216244252
Working Capital Days504451502535528455664952
ROCE %27%27%25%23%18%19%18%13%9%14%14%13%